RUO labeling
Does a 'Research Use Only' label decide whether a product is legal?
Plain English first, then the primary source. Education, not legal advice.
Interpretation
In short: the label describes an intended use, it does not create one. Conduct decides the legal question.
Plain English
No single label controls the legal status of a product. FDA has repeatedly said that the RUO or IUO designation is a labeling claim, and the agency looks past the label to how a product is actually distributed, marketed, and used. This is sometimes called the objective intent standard.
For in vitro diagnostic products specifically, FDA's regulation at 21 CFR 809.10(c)(2)(i) lets manufacturers label products RUO or IUO if they meet defined criteria, but FDA guidance explains that a manufacturer's own conduct, including sales calls, trade show materials, or clinical validation support, can show the product is intended for clinical diagnostic use regardless of the label.
The label is one piece of evidence among many. It is not a shield and it is not a permit.
Why it matters
- Suppliers who label a product RUO but market it for clinical or human use create a mismatch that FDA treats as evidence of an unapproved intended use.
- Buyers who see an RUO label should not assume the product has been evaluated for safety or efficacy for any human application.
Where the answer becomes fact-specific
The Foundation does not manufacture legal conclusions. These points change the analysis and may require qualified regulatory counsel.
- Whether the product is a drug, a device, or an IVD changes which regulation applies.
- The specific marketing materials, sales conversations, and customer base determine what FDA would consider the 'objective intent' of the seller.